Israel is Chosen to Participate in International Clinical Study to Test a Cure for COVID-19
Eight countries in the world were selected to partake in clinical research trials on the drug Kevzara, already in use as a medication for rheumatoid arthritis. The two-month study will involve 40 patients in Israel and about 300 internationally.
Presently, there are few and limited treatments available for patients infected with COVIDd-19, and all of these treatments are unproven and experimental. The study on Kevzara marks Israel’s first clinical research trial to identify an effective medical treatment.